Sort
53,477 grants matching “addiction”
Ascertaining Neurocircuitry to Enhance Neuromodulation Development ASCEND
$549,743Shawn M McClintock · Ut Southwestern Medical Center · R01 · FY2023 · MH
Targeting Hedonic Dysregulation to Address Chronic Pain and Opioid Misuse in Primary Care.
$549,658Eric Lee Garland · University Of Utah · R01 · FY2020 · DA
CAREER: Understanding Peripheral Neuromodulation to Enhance Non-drug Management of Chronic Pain
$549,656Bin Feng · University Of Connecticut · · FY2019 · ENG
Research Project 2 - Genomic Approaches to Pollutome Effects on Risk of Major Depression in Hispanic Pedigrees
$549,610John Blangero · University Of Texas Rio Grande Valley · U54 · FY2025 · HG
Preclinical Evaluation of Medications to Treat Polydrug Addiction
$549,606Nancy K. Mello · Mclean Hospital · R01 · FY2011 · DA
Polydrug Nanocarrier to Treat Opiate Addiction and HIV Disease
$549,593Madhavan P Nair · Florida International University · R01 · FY2009 · DA
Computational and Neural Modeling of Cue Reactivity in Addiction
$549,579Xiaosi Gu · Icahn School Of Medicine At Mount Sinai · R01 · FY2019 · DA
Large-Scale Discovery of Functional Genetic Variation in Rhesus Macaques
$549,490Jeffrey A Rogers · Baylor College Of Medicine · R24 · FY2011 · RR
Data-Based Methods for Just-In-Time Adaptive interventions in Alcohol Use
$549,466Susan A Murphy · Harvard University · R01 · FY2019 · AA
Neuropeptide Y Y1 Receptor Imaging Agents for Positron Emission Tomography
$549,437Neale S Mason · University Of Pittsburgh At Pittsburgh · R01 · FY2020 · AA
Quetiapine Pharmacotherapy for Cannabis Dependence
$549,423John J Mariani · New York State Psychiatric Institute Dba Research Foundation For Mental Hygiene, Inc · R01 · FY2015 · DA
Administrative Supplement to Support Strategies to Increase Participant Diversity, Inclusion and Engagement in EPPIC NET
$549,417Alexander Tan Limkakeng · Duke University · U24 · FY2021 · NS
The structural basis for pathway-selective signaling by the µ opioid receptor
$549,378Brian K Kobilka · Stanford University · R01 · FY2024 · DA
Delineating the dystopian nature of the cell cycle in cancer
$549,360Erik Knudsen · Roswell Park Cancer Institute Corp · R01 · FY2022 · CA
Nature and Predictors of Impaired Harm Avoidance in Polysubstance Abuse
$549,328Michael W. Otto · Boston University (Charles River Campus) · R33 · FY2022 · DA
Topiramate for alcohol and cocaine dependence
$549,223Kyle Matthew Kampman · University Of Pennsylvania · R01 · FY2006 · AA
Deterrents for prescription opioid abuse
$549,185Kevin B. Freeman · University Of Mississippi Med Ctr · R01 · FY2022 · DA
High-activity mutants of cocaine esterase for treatment of drug addiction
$549,174Chang-Guo Zhan · University Of Kentucky · R01 · FY2012 · DA
The Cascade of Care for Medicaid-Enrolled Youth with Opioid Use Disorder
$549,127Scott Evan Hadland · Massachusetts General Hospital · R01 · FY2025 · DA
Therapeutic Communities: A Three Country Comparison
$549,116David Kressel · National Development And Research Institutes, Inc. · R01 · FY2006 · DA
TREATMENT OF ADULT ADHD IN METHADONE PATIENTS
$549,103New York State Psychiatric Institute · R01 · FY2001 · DA
Parallel MRI for High Field Neuroimaging
$549,063Victor Andrew Stenger · University Of Hawaii At Manoa · R01 · FY2016 · DA
Brain Acetate and Ethanol Metabolism in Alcohol Dependence and Abuse
$549,020Graeme F Mason · Yale University · R01 · FY2013 · AA
Effects of a Preventive Intervention for Mexican Origin Adolescents
$548,980Nancy A Gonzales · Arizona State University-Tempe Campus · R01 · FY2011 · MH
Modeling Kappa Opioid Analgesic Mechanisms in Chronic Orofacial Pain Disorders
$548,956Jon David Levine · University Of California, San Francisco · R01 · FY2007 · DE